MARKET

GNPX

GNPX

Genprex Inc
NASDAQ
1.710
+0.130
+8.23%
After Hours: 1.750 +0.04 +2.34% 19:37 02/03 EST
OPEN
1.620
PREV CLOSE
1.580
HIGH
1.730
LOW
1.600
VOLUME
251.99K
TURNOVER
0
52 WEEK HIGH
2.670
52 WEEK LOW
0.9700
MARKET CAP
82.12M
P/E (TTM)
-3.6152
1D
5D
1M
3M
1Y
5Y
Benzinga's Top Ratings Upgrades, Downgrades For January 30, 2023
Benzinga · 4d ago
Dawson James Initiates Coverage On Genprex with Buy Rating, Announces Price Target of $3
Benzinga · 4d ago
--Dawson James Initiates Genprex at Buy Rating With $3 Price Target
--Dawson James Initiates Genprex at Buy Rating With $3 Price Target
MT Newswires · 4d ago
Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga · 01/06 18:16
BRIEF-Genprex Signs License To Additional Diabetes Technology With University Of Pittsburgh
Reuters · 01/05 12:11
Genprex Signs Exclusive License To Additional Diabetes Technology With The University Of Pittsburgh
Benzinga · 01/05 12:02
Why Enovix Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga · 01/04 18:17
HUYA, KALA and EIGR among mid-day gainers and losers
Seekingalpha · 12/28/2022 18:00
More
About GNPX
Genprex, Inc. is a clinical-stage gene therapy company. The Company is focused on developing treatments for cancer and diabetes. The Company's lead cancer drug candidate, REQORSA Immunogen therapy drug (also referred to as GPX-001), is being developed to treat non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). The active agent in REQORSA is a TUSC2 gene expressing plasmid that is encapsulated in a DOTAP cholesterol nanoparticle. TUSC2 is a multifunctional gene that helps in cancer suppression and normal cell regulation. The Company utilizes its ONCOPREX Nanoparticle Delivery System to deliver the TUSC2 gene expressing plasmid to cancer cells. Its diabetes gene therapy, also referred to as GPX-002, is designed to work by transforming alpha cells in the pancreas into functional beta-like cells, which can produce insulin but are distinct enough from beta cells to evade the body's immune system.

Webull offers kinds of Genprex Inc stock information, including NASDAQ:GNPX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GNPX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading GNPX stock methods without spending real money on the virtual paper trading platform.